亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

The potential (therapeutic) role of BAFF, FLT3L and IL-2 in immune disorders

作者
Matthias Kreuzaler
出处
期刊:University of Basel - edoc [University of Basel]
标识
DOI:10.5451/unibas-006173513
摘要

The TNF family member protein BAFF/BLyS is essential for B cell survival. In humans, increased \nconcentrations of soluble BAFF are found during different pathological conditions, which may be as \ndiverse as autoimmune diseases, B cell malignancies, and primary Ab deficiencies (PAD). We have \ndeveloped a sensitive ELISA for soluble human BAFF, which allows us to study some parameters that \nmight determine the level of soluble BAFF in circulation. We show that, patients suffering from PAD \nincluding severe functional B cell defects, such as BTK‐, BAFF‐R‐, or TACI‐deficiencies, were all found \nto have higher BAFF levels in their blood than asplenic individuals, patients having undergone anti‐ \nCD20 B cell depletion, chronic lymphocytic leukemia patients, or healthy blood donors. In a \ncomparable manner, transgenic mice constitutively expressing soluble human BAFF were found to \nhave higher concentrations of circulating human BAFF in the absence of B cells. Therefore, our data \nstrongly suggest that the steady‐state concentration of BAFF mainly depends on the number of B \ncells present as well as on the expression of BAFF‐binding receptors. Because most patients with PAD \nhave high levels of circulating BAFF, the increase in BAFF concentrations cannot compensate for the \ndefects in B cell development and function. \nIn a second study, we showed that treatment of mice with the fms‐like tyrosine kinase ligand (FLT3L) \nas well as with an IL‐2/αIL‐2 mAb complex (JES6‐1A12, S4B6) led to an expansion of the Treg \ncompartment. We show that this increased number of NTregs is due to proliferation of pre‐existing \nNTregs, likely due to favored interactions with the increased number of DCs. The increase of NTregs \nin the IL‐2/αIL‐2 complex treated mice is due to a direct effect of IL‐2 signaling. Thus the lifespan and \navailability of the IL‐2 molecules is prolonged due to the complex with the mAb and therefore \nstronger/longer signals via the IL‐2R can be achieved. We investigated the potential of FLT3L and IL‐ \n2/αIL‐2 pretreatment of mice and could show that administration of FLT3L could prevent death \ninduced by an acute GvHD in BDF1 mice. However, when we used a different mouse strain, \n(BM1xBM12)F1, no protection could be observed, even though the Treg cells increase in these mice \nwas similar to the one in BDF1 mice. By depleting the NK cell compartment of acute GvHD mice, we \ncould show that NTregs themselves are not protective in this system. \nIn a third study, the potential use of FLT3L and IL‐2/αIL‐2 complex (JES6‐1A12) pre‐treated recipients \nof solid allografts were investigated. To test whether Flt3L treatment was effective in prolonging \nallograft survival we used the transplant model where the tail skin from a BM12 mouse was \ntransferred to the trunk of B6 mice. An IL‐2/αIL‐2 complex pre‐treatment, previously shown to be \nhighly effective in a pancreatic islet allograft transplant model, was used as a control. All PBS treated \nB6 mice rejected the graft within 12 days, the IL‐2/αIL‐2 treated mice kept their allografts for a \nmaximum of 70 days +/‐ 5 days. In the FLT3L treated group, 12,5% of the mice rejected the graft with \nsimilar kinetics as the PBS treated mice. 62,5% of the mice showed a delayed rejection of the graft by \n4‐14 days. Only 25% of recipient mice had a graft survival similar to the IL‐2/αIL‐2 treated mice. \nReducing the numbers of Tregs in FLT3L treated mice by a αCD25 mAb injection resulted in a graft \nsurvival time similar to that observed in PBS treated mice suggesting that the FLT3L induced \nprolonged graft survival was due to increased numbers of Tregs. \nTaken together these findings indicate that FLT3L treatment could be a possible prophylactic therapy \nfor preventing solid organ rejection.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
千鸟完成签到 ,获得积分10
刚刚
3秒前
茅文荣发布了新的文献求助10
5秒前
bkagyin的应助被君齐采纳,获得10
7秒前
草莓布丁子完成签到 ,获得积分10
7秒前
yy完成签到 ,获得积分10
8秒前
uss完成签到,获得积分10
9秒前
小烟云完成签到 ,获得积分10
10秒前
犹豫静白完成签到,获得积分10
10秒前
草莓布丁子关注了科研通微信公众号
10秒前
10秒前
koman完成签到,获得积分10
10秒前
万寿宫人发布了新的文献求助60
12秒前
12秒前
无花果的应助被如意的灵阳采纳,获得10
13秒前
13秒前
13秒前
听话的老太完成签到,获得积分10
15秒前
ly发布了新的文献求助10
15秒前
SZHGYMC发布了新的文献求助10
16秒前
青苹果qq完成签到 ,获得积分10
16秒前
fengjingjing发布了新的文献求助10
17秒前
17秒前
21秒前
科研通AI6.2的应助被君齐采纳,获得10
22秒前
24秒前
颓废系完成签到 ,获得积分20
24秒前
榴莲完成签到,获得积分10
25秒前
26秒前
赘婿的应助被fengjingjing采纳,获得10
26秒前
nangua完成签到,获得积分10
26秒前
27秒前
Leo完成签到,获得积分10
27秒前
27秒前
佳1发布了新的文献求助10
31秒前
32秒前
33秒前
土土桔子糖完成签到 ,获得积分10
35秒前
ding的应助被美丽的帆布鞋采纳,获得10
37秒前
tnedance完成签到,获得积分20
38秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194962
求助须知:如何正确求助?哪些是违规求助? 9580711
关于积分的说明 21872442
捐赠科研通 7794663
什么是DOI,文献DOI怎么找? 3437819
关于科研通互助平台的介绍 2561143
邀请新用户注册赠送积分活动 2484511